Saroglitazar

Name: Saroglitazar in Primary biliary cholangitis: Clinical presentation - signs and symptoms
Published: 2026-09-14T15:39:06-04:00

Primary biliary cholangitis

Manufacturer: Zydus Therapeutics
Regulatory submission: NDA submitted by May 2026
Launch: Anticipated in April 2027, the start of Zydus fiscal year 2028
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Disease description

Clinical presentation - signs and symptoms

2 evidence topics · 1 source

Constitutional symptoms: fatigue

“The most common symptoms of primary biliary cholangitis are” (opens the source at this quote in a new tab)
“feeling tired” (opens the source at this quote in a new tab)

Dermatologic symptoms: pruritus

“itchy skin” (opens the source at this quote in a new tab)